GBM cell models were constructed by mixing CD70+ and CD70– GBM cells in different proportions (80%, 50%, and 20% CD70+) in vitro (Fig. 7A and B) to mimic antigen mutations or loss (AML) in GBM. This evidence concerns the gene CD70 and acute myeloid leukemia.